Bio Plus Co., Ltd (KOSDAQ:099430)
4,970.00
-25.00 (-0.50%)
Mar 6, 2026, 12:39 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 307.39 billion as of March 5, 2026. Its market cap has decreased by -18.74% in one year.
Market Cap
307.39B
Enterprise Value
353.21B
Revenue
96.80B
Ranking
n/a
PE Ratio
21.00
Stock Price
4,970.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 307.39B, a decrease of -31.90%. That is a compound annual growth rate of -8.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 307.39B | -0.70% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InBody Co.,Ltd | 349.31B |
| ToolGen | 379.43B |
| DRTECH | 145.42B |
| i-SENS | 549.38B |
| Curexo | 557.18B |
| WON TECH | 593.77B |
| T&R Biofab | 131.29B |
| Osang Healthcare Co.,Ltd | 125.68B |